Drug
Gensci136 For
Gensci136 For: highest development phase Phase 1/2, developed by Changchun GeneScience Pharmaceutical Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Changchun GeneScience Pharmaceutical Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| GenSci136 for injection NCT07936084 | Phase 1/2 | Patients With MG (gMG and oMG) |
Latest
No recent events.
Follow Gensci136 For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.